Evidence map›Paper›PMID 27911902›Full record

ArticlePLoS neglected tropical diseases2016

Comparison of the Estimated Incidence of Acute Leptospirosis in the Kilimanjaro Region of Tanzania between 2007-08 and 2012-14.

Michael J Maze, Holly M Biggs, Matthew P Rubach, Renee L Galloway, Shama Cash-Goldwasser, Kathryn J Allan, Jo E B Halliday, Julian T Hertz, Wilbrod Saganda, Bingileki F Lwezaula and 4 more

Open access · goldAbstract readComparative Study
In one paragraph

Article in PLoS neglected tropical diseases, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 3 pooled it
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 3 syntheses or guidelines pooled it, 29 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Observational
  13. Review
  14. Article
  15. Molecular Detection and Typing of PathogenicThe American journal of tropical medicine and hygiene · 2020
    Article
  16. Article
  17. Article
  18. Prevalence ofAfrican health sciences · 2020
    Article
  19. Review
  20. Fever, bacterial zoonoses, and One Health in sub-Saharan Africa.Clinical medicine (London, England) · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 8 institutions in 4 countries.

Michael J MazeCentre for International Health, University of Otago, Dunedin, New Zealand.
Holly M BiggsDivision of Infectious Diseases, Duke University Medical Center, Durham, North Carolina, United States of America.
Matthew P RubachKilimanjaro Christian Medical Centre, Moshi, Tanzania.
Renee L GallowayCenters for Disease Control and Prevention, Bacterial Special Pathogens Branch, Atlanta, Georgia, United States of America.
Shama Cash-GoldwasserKilimanjaro Christian Medical Centre, Moshi, Tanzania.
Kathryn J AllanBoyd Orr Centre for Population and Ecosystem Health, Institute of Biodiversity, Animal Health and Comparative Medicine, University of Glasgow, Glasgow, United Kingdom.
Jo E B HallidayBoyd Orr Centre for Population and Ecosystem Health, Institute of Biodiversity, Animal Health and Comparative Medicine, University of Glasgow, Glasgow, United Kingdom.
Julian T HertzDuke Global Health Institute, Duke University, Durham, North Carolina, United States of America.
Wilbrod SagandaMawenzi Regional Referral Hospital, Moshi, Tanzania.
Bingileki F LwezaulaMawenzi Regional Referral Hospital, Moshi, Tanzania.
Sarah CleavelandMawenzi Regional Referral Hospital, Moshi, Tanzania.
Blandina T MmbagaKilimanjaro Christian Medical Centre, Moshi, Tanzania.
Venance P MaroKilimanjaro Christian Medical Centre, Moshi, Tanzania.
John A CrumpCentre for International Health, University of Otago, Dunedin, New Zealand.
St. Francis Referral Hospital · TZDuke Institute for Health Innovation · USKilimanjaro Christian Medical Centre · TZUniversity of Glasgow · GBUniversity of Otago · NZCenters for Disease Control and Prevention · USDuke Medical Center · USDuke University · US

Funding

Fogarty International Clinical Research Scholars Support Center @ Vanderbilt-AAMCR24TW007988 · FIC · VANDERBILT UNIVERSITY · PI VERMUND, STEN H. · 2007 to 2011
$27.6M
Ruth L. Kirschstein National Research Service Award (NRSA)- T32T32AI007392 · NIAID · DUKE UNIVERSITY · PI Amy Lynn Corneli, Guido Ferrari · 1990 to 2026
$9.8M
University of California Global Health Institute Program for Fellows and ScholarsR25TW009343 · FIC · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI COHEN, CRAIG R, STRATHDEE, STEFFANIE A. · 2012 to 2017
$6.4M
Vanderbilt-Emory-Cornell-Duke Consortium for Global Health Fellows (VECDor)R25TW009337 · FIC · VANDERBILT UNIVERSITY MEDICAL CENTER · PI HEIMBURGER, DOUGLAS CORBETT, VERMUND, STEN H. · 2012 to 2016
$6.3M
International Clinical Trials UnitU01AI062563 · NIAID · DUKE UNIVERSITY · PI BARTLETT, JOHN A · 2004 to 2007
$4.0M
Investigating Febrile Deaths in Tanzania (INDITe)R01AI121378 · NIAID · DUKE UNIVERSITY · PI RUBACH, MATTHEW P · 2016 to 2020
$2.7M
The Impact and Society Ecology of Bacterial Zoonoses in Northern Tanzania: UnderR01TW009237 · FIC · DUKE UNIVERSITY · PI CRUMP, JOHN ANDREW · 2011 to 2014
$1.7M
Viral Zoonoses and Severe Febrile Illness in Northern TanzaniaK23AI116869 · NIAID · DUKE UNIVERSITY · PI RUBACH, MATTHEW P · 2016 to 2020
$896k
Biotechnology and Biological Sciences Research Council BB/J010367/1Biotechnology and Biological Sciences Research Council BB/L017679Biotechnology and Biological Sciences Research Council BB/L018845Biotechnology and Biological Sciences Research Council BB/L018845/1Biotechnology and Biological Sciences Research Council BB/L018926Biotechnology and Biological Sciences Research Council BB/L018926/1FIC NIH HHS R01 TW009237FIC NIH HHS R24 TW007988FIC NIH HHS R25 TW009337FIC NIH HHS R25 TW009343NIAID NIH HHS K23 AI116869NIAID NIH HHS R01 AI121378NIAID NIH HHS T32 AI007392NIAID NIH HHS U01 AI062563Wellcome TrustWellcome Trust 096400/Z/11/Z
6 · The paper itself

Abstract

backgroundThe sole report of annual leptospirosis incidence in continental Africa of 75-102 cases per 100,000 population is from a study performed in August 2007 through September 2008 in the Kilimanjaro Region of Tanzania. To evaluate the stability of this estimate over time, we estimated the incidence of acute leptospirosis in Kilimanjaro Region, northern Tanzania for the time period 2012-2014. METHODOLOGY AND PRINCIPAL

findingsLeptospirosis cases were identified among febrile patients at two sentinel hospitals in the Kilimanjaro Region. Leptospirosis was diagnosed by serum microscopic agglutination testing using a panel of 20 Leptospira serovars belonging to 17 separate serogroups. Serum was taken at enrolment and patients were asked to return 4-6 weeks later to provide convalescent serum. Confirmed cases required a 4-fold rise in titre and probable cases required a single titre of ≥800. Findings from a healthcare utilisation survey were used to estimate multipliers to adjust for cases not seen at sentinel hospitals. We identified 19 (1.7%) confirmed or probable cases among 1,115 patients who presented with a febrile illness. Of cases, the predominant reactive serogroups were Australis 8 (42.1%), Sejroe 3 (15.8%), Grippotyphosa 2 (10.5%), Icterohaemorrhagiae 2 (10.5%), Pyrogenes 2 (10.5%), Djasiman 1 (5.3%), Tarassovi 1 (5.3%). We estimated that the annual incidence of leptospirosis was 11-18 cases per 100,000 population. This was a significantly lower incidence than 2007-08 (p<0.001).

conclusionsWe estimated a much lower incidence of acute leptospirosis than previously, with a notable absence of cases due to the previously predominant serogroup Mini. Our findings indicate a dynamic epidemiology of leptospirosis in this area and highlight the value of multi-year surveillance to understand leptospirosis epidemiology.

Indexed as

Acute DiseaseAdolescentAgglutination TestsAntibodies, BacterialChildChild, PreschoolFemaleFeverHumansIncidenceLeptospiraLeptospirosisMaleTanzaniaYoung AdultAntibodies, Bacterial

Identifiers

PMID27911902
PMCPMC5135036
OpenAlexW2558084542

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.